Search

Your search keyword '"Johansson, Peter A."' showing total 46 results

Search Constraints

Start Over You searched for: Author "Johansson, Peter A." Remove constraint Author: "Johansson, Peter A." Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
46 results on '"Johansson, Peter A."'

Search Results

1. Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.

2. Living with non‐cardiac chest pain – An inductive qualitative interview study of spouses' perspectives.

3. Development and performance of a sleep estimation algorithm using a single accelerometer placed on the thigh: an evaluation against polysomnography.

4. Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment.

5. Systematic review and meta‐analysis of genomic alterations in acral melanoma.

6. Accelerometer derived physical activity patterns in 27.890 middle‐aged adults: The SCAPIS cohort study.

7. The effect of nurse‐led Internet‐based cognitive behavioural therapy for insomnia on patients with cardiovascular disease: A randomized controlled trial with 6‐month follow‐up.

8. The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial.

9. A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies.

10. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study.

11. ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patients.

12. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.

13. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.

14. Genetic variation in <italic>IL28B</italic> (<italic>IFNL3</italic>) and response to interferon‐alpha treatment in myeloproliferative neoplasms.

15. DECLARE‐TIMI 58: Participants’ baseline characteristics.

16. Less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10—A mechanism behind reduced cardiovascular mortality?

17. Sex‐specific associations between self‐reported sleep duration, depression, anxiety, fatigue and daytime sleepiness in an older community‐dwelling population.

18. Risk factors for vascular complications and treatment patterns at diagnosis of 2389 PV and ET patients: Real-world data from the Swedish MPN Registry.

19. A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera.

20. Mutation load in melanoma is affected by MC1R genotype.

21. Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

22. Improved MPL mutation screening with multiplex PCR and capillary electrophoresis.

23. Effect of additives on the melt rheology and thermal degradation of poly[(R)-3-hydroxybutyric acid].

24. Jamming Detection in GNSS Receivers: Performance Evaluation of Field Trials.

25. Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population.

26. Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

27. Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.

28. Depression and the delay between symptom onset and hospitalization in heart failure patients.

29. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.

30. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme.

31. Partially erupted third molars as a potential source of infection in patients receiving peripheral stem cell transplantation for malignant diseases: a retrospective study.

32. AML transformation in 56 patients with Ph− MPD in two well defined populations.

33. Global perceived health and ten-year cardiovascular mortality in elderly primary care patients with possible heart failure

34. Confirmation of a BRAF mutation-associated gene expression signature in melanoma.

35. Obstructive sleep apnoea syndrome – patients' perceptions of their sleep and its effects on their life situation.

36. Consequences and Predictors of Depression in Patients With Chronic Heart Failure: Implications for Nursing Care and Future Research.

37. The Measurement and Prevalence of Depression in Patients With Chronic Heart Failure.

38. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.

41. Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia.

42. The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia.

43. Patient satisfaction with nursing care in the context of health care: a literature study.

45. Iris melanoma in an Australian cohort.

Catalog

Books, media, physical & digital resources